hero bg

Microbiome decoded ∙
Healthcare transformed

We are a clinical stage biopharmaceutical company developing first-in-class immunomodulatory drugs based on our unique ability to de-code the gut microbiome’s interaction with the immune system.

We are a clinical stage biopharmaceutical company developing first-in-class immunomodulatory drugs based on our unique ability to de-code the gut microbiome’s interaction with the immune system.

Our unrivalled ability to identify microbiome-driven small proteins and peptides drugs has allowed us to develop two highly promising pipelines of first-in-class drugs targeting cancer and immune diseases.

Microbiome Decoded

Database of 20M full length proteins from the gut microbiome

Specifically designed drug discovery platform to decipher this database

Two transformative drug pipelines for cancer and immune diseases

A new class of therapeutics poised to improve human health

Healthcare transformed

Enterome France

Headquarters
94/96 avenue Ledru-Rollin 75011 Paris – France
Tel: +33 (0)1 75 77 27 85
Lab facilities
Biocluster Genopole
5 rue Henri Desbruères – 91030 Evry Cedex